Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials

PURPOSE: To quantify clinical trial participants’ and investigators’ judgments with respect to the relative importance of efficacy and safety attributes of antipsychotic treatments for schizophrenia, and to assess the impact of formulation and adherence. METHODS: Discrete-choice experiment surveys w...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Eva G, Hauber, Brett, Gopal, Srihari, Fairchild, Angie, Pugh, Amy, Weinstein, Rachel B, Levitan, Bennett S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085312/
https://www.ncbi.nlm.nih.gov/pubmed/27799749
http://dx.doi.org/10.2147/PPA.S114172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085312/
https://www.ncbi.nlm.nih.gov/pubmed/27799749
http://dx.doi.org/10.2147/PPA.S114172

Ejemplares similares